Oxcarbazepine Tablets, 300 mg, 100 tablet bottles, Rx Only. Distributed by: Caraco Pharmaceutical Laboratories, Ltd., 1150 Elijiah McCoy Drive, Detroit, MI, 48202. Manufactured by: Sun Pharmaceutical Ind. Ltd., Acme Plaza, Andheri-Kurla Road, Andheri (East), Mumbai-400 059, India. NDC 62756-184-88, Rx only, 100 Tablets; Pharmacist: Dispense the Medication Guide provided separately to each patient. Each film-coated tablet contains 300 mg oxcarbazepine, USP, Usual Dosage: See package insert, Dispense in tight container (USP) tore at 25 C (77 F) excursions permitted.... Distributed by Caraco Pharmaceuticals Detroit, MI....
Published February 19, 2014 · Recall initiated: January 29, 2014
Summary
FDA records drug Class II recall D-1081-2014, published February 19, 2014 and initiated January 29, 2014. Recalling firm: Caraco Pharmaceutical Laboratories Ltd.; Status: Terminated; Reported quantity: 7005 bottles; Lot: Lot #: JKM7075A, Expiry:10/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet Specifications: Broken Tablets Present.
What to do
Voluntary: Firm initiated · E-Mail
Get an email if OXCARBAZEPINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- OXCARBAZEPINE
- Manufacturer
- Caraco Pharmaceutical Laboratories Ltd.
- Distributor
- Nationwide
- UPC
- 0362756183834
- Lot
- Lot #: JKM7075A, Expiry:10/15
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAOxcarbazepine Tablets 600mg, packaged in a) 100- count bottles (NDC 62756-185-88), b) 500-count bottles (NDCDecember 28, 2022
- FDADiclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only,February 19, 2014
- FDAVoLumen Barium Sulfate Suspension (0.1 % w/v, 0.1 ww/w), 450 mL bottle, Rx Only. Manufactured by E-Z-EM CanadaFebruary 19, 2014
- FDAHemochron Jr. Citrate APTT Cuvette 510(k) K014008 A unitized microcoagulation test intended to be used inFebruary 12, 2014
- FDAThe Symbionic Leg is an integrated prosthetic leg for transfemoral and knee disarticulation amputees. TheFebruary 12, 2014
- FDALOCATOR® Implant Attachment System. The LOCATOR® Implant Attachment System is a universal hinge, resilientFebruary 12, 2014
Questions about this recall
Was Oxcarbazepine Tablets, 300 mg, 100 tablet bottles, Rx Only. Distributed by: Caraco Pharmaceutical Laboratories, Ltd., 1150 Elijiah McCoy Drive, Detroit, MI, 48202. Manufactured by: Sun Pharmaceutical Ind. Ltd., Acme Plaza, Andheri-Kurla Road, Andheri (East), Mumbai-400 059, India. NDC 62756-184-88, Rx only, 100 Tablets; Pharmacist: Dispense the Medication Guide provided separately to each patient. Each film-coated tablet contains 300 mg oxcarbazepine, USP, Usual Dosage: See package insert, Dispense in tight container (USP) tore at 25 C (77 F) excursions permitted.... Distributed by Caraco Pharmaceuticals Detroit, MI.... recalled?
Yes. FDA published recall D-1081-2014 on February 19, 2014. Reported hazard: Failed Tablet Specifications: Broken Tablets Present.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: OXCARBAZEPINE. UPC: 0362756183834.